SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-24-000026
Filing Date
2024-02-12
Accepted
2024-02-12 07:05:53
Documents
58
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20231231.htm   iXBRL 10-Q 1330235
2 EX-10.1 exhibit101-20231231q3.htm EX-10.1 61787
3 EX-31.1 exhibit311-20231231q3.htm EX-31.1 9515
4 EX-31.2 exhibit312-20231231q3.htm EX-31.2 9416
5 EX-32.1 exhibit321-20231231q3.htm EX-32.1 4466
6 EX-32.2 exhibit322-20231231q3.htm EX-32.2 4487
  Complete submission text file 0001764013-24-000026.txt   5144733

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20231231.xsd EX-101.SCH 28034
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20231231_cal.xml EX-101.CAL 39133
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20231231_def.xml EX-101.DEF 196535
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20231231_lab.xml EX-101.LAB 502497
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20231231_pre.xml EX-101.PRE 329104
60 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20231231_htm.xml XML 411666
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 24617346
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)